Editor’s Letter

Published in:
Volume 4 / Year 2015 / Issue 4

Fourth and final issue of GaBI Journal’s fourth volume

Page: 157-8

This last issue of 2015 starts with a Commentary by Drs Christoph Baumgärtel and Brian Godman concerning the approval of generic versions of narrow therapeutic margin products; including immunosuppressant drugs.… Read More »

Go Back Print